CN103954704A - Method for assaying content of blood clam protein - Google Patents

Method for assaying content of blood clam protein Download PDF

Info

Publication number
CN103954704A
CN103954704A CN201410186505.1A CN201410186505A CN103954704A CN 103954704 A CN103954704 A CN 103954704A CN 201410186505 A CN201410186505 A CN 201410186505A CN 103954704 A CN103954704 A CN 103954704A
Authority
CN
China
Prior art keywords
blood clam
polypeptide
content
protein
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410186505.1A
Other languages
Chinese (zh)
Other versions
CN103954704B (en
Inventor
苏静
王丽
赵颖
许翠萍
张晶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Zhonghong Kang Pharmaceutical Technology Development Co Ltd
Original Assignee
Jinan Kangzhong Pharmaceutical Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan Kangzhong Pharmaceutical Research and Development Co Ltd filed Critical Jinan Kangzhong Pharmaceutical Research and Development Co Ltd
Priority to CN201410186505.1A priority Critical patent/CN103954704B/en
Publication of CN103954704A publication Critical patent/CN103954704A/en
Application granted granted Critical
Publication of CN103954704B publication Critical patent/CN103954704B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a method for assaying the content of blood clam protein. The method is characterized in that firstly, polypeptide in an assayed sample is determined as the blood clam protein through a high efficiency liquid chromatographic method by use of a gel chromatographic column and then the content is assayed through a nitrogen determination method. In a preparation, every 1g of blood clam extract contains not less than 0.12g of blood clam polypeptide, and the higher the content is, the better the curative effect is. The method can be used for assaying the content of various preparations of the blood clam extract to guarantee the product quality of the blood clam preparations during production and use, and thus the curative effect of medicaments is guaranteed.

Description

A kind of content assaying method of blood clam protein
Technical field
The present invention relates to medicine detection method, be specifically related to a kind of content assaying method of blood clam protein, belong to field of pharmaceutical technology.
Background technology
Blood clam meat is containing rich in protein, vitamin and the necessary amino acid of human body, just there is edible, medical value from ancient times, " medical center bun will " note " blood clam meat bushing blood, loose hemostasis, relieving restlessness are sobered up, the dissolving phlegm of broken knot ", " Japan hanako materia medica " note " blood clam meat benefit color ".In recent years, research report shows that blood clam has antitumor action, has effect of removing interior free yl, improving immunity of organisms.Blood clam meat preparation has good therapeutic action to kinds cancers such as lung cancer, kidney, cancer of the stomach, liver cancer, and security is good.
One of main bioactive ingredients of blood clam according to bibliographical information blood clam polypeptide, have protect the liver, antitumor, regulate immune effect.The doctoral advisor Yu Rongmin of Ji'nan University professor report on January 5th, 2011, fresh blood clam shells, after homogenate, centrifugal, dialysis, freeze-drying, make blood clam polypeptide extract, method is measured the impact on mice spleen lymphocytes proliferation and the impact on mouse NK cell killing activity; On the impact of Phagocytosis By The Peritoneal Macrophages In Mice; The variation in mouse spleen lymphocyte cycle; On the impact of major cytokine IFN-γ and IL-4 secretion level.Result blood clam polypeptide extract can significantly promote mice spleen lymphocytes proliferation, strengthens Turnover of Mouse Peritoneal Macrophages and engulfs dimethyl diaminophenazine chloride activity and mouse NK cell killing activity; Promote splenic lymphocyte G0/G1 phase to DNA synthesis phase (s phase) to transform; Collaborative ConA effect, can increase the secretion of IFN-γ, and can suppress the secretion of IL-4.The expensive report that waits of the Dou Chang of China Medicine University; with blood clam meat hydrolyzate mouse stomach; result: the active rising of serum glutamic pyruvic transminase that phenixin, thio-ethylamine and prednisolone are caused all has obvious reducing effect, shows that blood clam hydrolyzate has significant protective effect to Experimental Hepatic Damage.
We test and find that blood clam polypeptide can obviously suppress the expression of hepatitis B surface antigen and E antigen, and hepatitis B DNA is had to inhibiting effect.
Protein is the base substance of vital movement, all animals and plants life entities all contain proteins and peptides, in the situation that cannot determining protein source, just can not ensure the validity of medicine, content that can not Accurate Determining protein, just cannot in producing and using, ensure product quality, and then pharmaceutical effectiveness can not be guaranteed.
Existing document does not also have the report of blood clam polypeptide specificity and assay.
Summary of the invention
The object of the invention is to overcome the deficiencies in the prior art, a kind of content assaying method of blood clam polypeptide is provided, make blood clam preparation in producing and using, effectively ensure product quality.
A content assaying method for blood clam protein and peptide, is characterized in that first determining that by gel chromatographic columns high performance liquid chromatography the polypeptide in sample is blood clam polypeptide, then measures content with nitriding, and concrete steps are as follows:
(1) chromatographic condition and system flexibility: the gel chromatographic columns that is filling agent with hydrophilic spherical superpolymer; Taking the phosphate buffer of 0.05mol/L as mobile phase; Detecting wavelength is 280 nm; Column temperature: 25 DEG C; Flow velocity 0.4ml/min; Detect wavelength 280nm; Number of theoretical plate calculates and is not less than 5000 by protein molecular weight 100000;
(2) take sample 10g, add 12 times of ultrasonic extraction 30 min of water, centrifugal 10 min, get upper strata liquid, filter, filtrate is mark 60%(w/v by volume) add ammonium sulfate, 0~4 DEG C of placement is spent the night, centrifugal, gets precipitation, the 10ml that adds water dissolves, and the ammonium bicarbonate soln taking 1% is dislysate, the dialysis membrane that is 3500 with molecular cut off, under 0~4 DEG C of condition, fully dialysis, is transferred to solution in dialysis membrane in 50ml measuring bottle water constant volume, 0~4 DEG C of preservation, obtains blood clam polypeptide solution;
(3) get blood clam polypeptide solution 10 μ l, injection liquid chromatography, measures, and records collection of illustrative plates; If there is the characteristic peak of blood clam polypeptide in collection of illustrative plates within retention time 15.6min ± 5%, its molecular weight is 88070, proceeds following operation, as nothing is judged to adulterant;
(4) take sample 0.5-2g, add 20-40 times of water, ultrasonic making is uniformly dispersed, add 10-20% trichloroacetic acid 15-40ml, mix, leave standstill 20-50 minute, filter, get filter paper and filter residue and drying, according to annex IX L first method of " Chinese Pharmacopoeia " version in 2010, n2 method is measured the content of blood clam polypeptide;
We are through repetition test discovery, and in preparation, every g blood clam extract must not be less than 0.12g containing polypeptide, and content is higher, better efficacy.
The sample protein matter content of blood clam extract after vacuum drying is 60%, and in the time of the research of blood clam effective constituent, we find, the polypeptide of little molecular weight is antineoplastic principal ingredient, and the protein biological activity of macromolecule is low, and pharmacological effect is poor.And the blood clam protein of macromolecule and stalwart blood clam, mud blood clam, flower clam, Scallop Extract, its contained polypeptide molecular weight is different from blood clam polypeptide, use gel chromatographic columns high effective liquid chromatography for measuring, in collection of illustrative plates within retention time 15.6min ± 5% characteristic peak without blood clam polypeptide, therefore strong by the content specificity of method mensuration blood clam polypeptide of the present invention, can ensure that the medicine of preparing with blood clam is effectively with quality controllable.
For the ease of understanding the present invention, special further illustrate by test example below:
One, two batches of blood clam extract tablet samples assays
(1) chromatographic condition and system flexibility: the gel chromatographic columns that is filling agent with hydrophilic spherical superpolymer; Taking the phosphate buffer of 0.05mol/L as mobile phase; Detecting wavelength is 280 nm; Column temperature: 25 DEG C; Flow velocity 0.4ml/min; Detect wavelength 280nm; Number of theoretical plate calculates and is not less than 5000 by protein molecular weight 100000;
(2) take the each 10g of sample, add respectively 12 times of ultrasonic extraction 30 min of water, centrifugal 10 min, get upper strata liquid, filter, filtrate is mark 60%(w/v by volume) add ammonium sulfate, 0~4 DEG C of placement is spent the night, centrifugal, gets precipitation, the 10ml that adds water dissolves, and the ammonium bicarbonate soln taking 1% is dislysate, the dialysis membrane that is 3500 with molecular cut off, under 0~4 DEG C of condition, fully dialysis, is transferred to solution in dialysis membrane in 50ml measuring bottle water constant volume, 0~4 DEG C of preservation, obtains blood clam polypeptide solution;
(3) get blood clam polypeptide solution 10 μ l, injection liquid chromatography, measures, and records collection of illustrative plates; In blood clam extract formulation tablet A sample collection of illustrative plates, have a sharp-pointed characteristic peak at retention time 15.537min, its molecular weight is 88070; In blood clam extract formulation tablet B sample characteristic collection of illustrative plates, have a sharp-pointed characteristic peak at retention time 15.698min, its molecular weight is 88070.Result shows that two batches of blood clam extract tablets are all to make with blood clam.Proceed assay;
(4) take the each 0.5-2g of sample, add respectively 20-40 times of water, ultrasonic making is uniformly dispersed, and adds 10-20% trichloroacetic acid 15-40ml, mixes, leave standstill 20-50 minute, filter, get filter paper and filter residue and drying, according to annex IX L first method of " Chinese Pharmacopoeia " version in 2010, n2 method is measured the content of blood clam polypeptide, calculates: every g blood clam polypeptide 0.45g in preparation A sample; Every g blood clam polypeptide 0.15 in preparation B sample.
Two, two batches of blood clam extract tablet drug effects comparison
Test method: choose 10 of healthy mices, inoculation lung cancer cell line (2*105/ only), after inoculation 14d, peels off tumour under aseptic condition, makes cell suspension with Potter-Elvehjem Tissue Grinders.By 30 of healthy mices, be divided at random 3 groups, containing cell number 1*105/ only respectively organize cell suspension 0.2ml(that equal tail vein accepts above-mentioned preparation).Give respectively preparation A, B 0.25g/kg intravenous injection, blank group injection equivalent physiological saline.Each group all once a day, continuous 10 days.
Observation item: stop observation post administration and respectively organize body weight mass change, survival day, calculates existence rate elongation LS=[(medication group survival day/control group survival day as follows)]-1*100%.Put to death animal and claim lung weight, calculate the heavy index of lung.The ratio * 100% of heavy heavy (the mg)/body weight of index=mouse lung of lung (10g).
The results are shown in Table:
Preparation A, B are all being better than blank group aspect survival day, the heavy index of existence rate elongation, lung, and the high preparation A curative effect of content is better than preparation B, show that blood clam extract tablet anticancer effect is definite, and dosage are higher, and effect is better.
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Get fresh blood clam meat, fragmentation, crosses 40 mesh sieves, adds 1 times of water gaging, extracts 4 hours extracting liquid filtering, centrifugal (2000 revs/min) 10 DEG C of following stirrings.Get above-mentioned centrifugate freeze-drying, obtain blood clam extract.
In blood clam extract characteristic spectrum, there is a sharp-pointed characteristic peak " peak S " at retention time 15.537min.Its molecular weight is 88070.Result shows that blood clam extract is to make with blood clam.Proceed assay.
Get blood clam extract porphyrize, precision takes 1.985g, adds 30 times of water, and ultrasonic making is uniformly dispersed, and adds 10% trichloroacetic acid 40ml, mixes, and leaves standstill 50 minutes, filters, and gets filter paper and filter residue and drying, obtains test sample.Test sample is measured according to n2 method (annex IX L first method of " Chinese Pharmacopoeia " version in 2010), and the every g of blood clam extract is containing blood clam polypeptide 0.25g.
Embodiment 2
Get dry blood clam meat, pulverize, cross 80 mesh sieves, add the water of 10 times of amounts, heating is extracted 2 times, and each 1 hour, merge extract, filter, get filtrate, being concentrated into relative density is 1.04~1.06(60 DEG C) time, centrifugal (2000 revs/min).Get above-mentioned centrifugate below 80 DEG C, drying under reduced pressure, pulverizes, and obtains blood clam extract.Extract is made to tablet.
In blood clam extract tablet characteristic spectrum, there is a sharp-pointed characteristic peak " peak S " at retention time 15.537min.Its molecular weight is 88070.Result shows that blood clam extract tablet is to make with blood clam, proceeds assay.
Get tablet porphyrize prepared by blood clam extract, precision takes 1.523g, containing blood clam extract 1.218g, adds 20 times of water, and ultrasonic making is uniformly dispersed, and adds 20% trichloroacetic acid 30ml, mixes, and leaves standstill 35 minutes, filters, and gets filter paper and filter residue and drying, obtains test sample.Test sample is measured according to n2 method (annex IX L first method of " Chinese Pharmacopoeia " version in 2010), and the every g of blood clam extract is containing blood clam polypeptide 0.16g.
Embodiment 3
Prepare blood clam extract according to the blood clam method for preparing extractive in embodiment 2, extract is made to capsule.
Get capsule 's content and differentiate, in result reality blood clam extract characteristic spectrum, have a sharp-pointed characteristic peak " peak S " at retention time 15.537min.Its molecular weight is 88070, and result shows that blood clam extract tablet is to make with blood clam, proceeds assay.
Get capsule 's content porphyrize, precision takes 0.572, containing blood clam extract 0.515g, adds 40 times of water, and ultrasonic making is uniformly dispersed, and adds 15% trichloroacetic acid 15ml, mixes, and leaves standstill 20 minutes, filters, and gets filter paper and filter residue and drying, obtains test sample.Test sample is measured according to n2 method (annex IX L first method of " Chinese Pharmacopoeia " version in 2010), and the every g of blood clam extract is containing blood clam polypeptide 0.06g.
Embodiment 4
According to the blood clam method for preparing extractive index blood clam extract in embodiment 2, extract is prepared into granule.
Get granule content and differentiate, concrete steps are as follows:
Chromatographic condition and system flexibility: the gel chromatographic columns that is filling agent with hydrophilic spherical superpolymer; Taking the phosphate buffer of 0.05 mol/L as mobile phase; Detecting wavelength is 280 nm; Column temperature: 25 DEG C; Flow velocity: 0.4ml/min.Number of theoretical plate is calculated as 8000 by protein molecular weight 100000.
Capsule 's content porphyrize is got in the preparation of blood clam extract solution, take 10g, add 12 times of ultrasonic extraction 30 min of water, centrifugal 10 min, get upper strata liquid, filter, filtrate is mark 60%(w/v by volume) add ammonium sulfate, 0~4 DEG C of placement is spent the night, centrifugal, get precipitation, the 10ml that adds water dissolves, ammonium bicarbonate soln taking 1% is dislysate, the dialysis membrane that is 3500 with molecular cut off, fully dialysis under 0~4 DEG C of condition (the BaCl2 solution with 1% checks whether sulfate ion dialyses completely), solution in dialysis membrane is transferred in 50ml measuring bottle, water constant volume, 0~4 DEG C of preservation, obtain blood clam polypeptide test sample.
Get blood clam protein (polypeptide) test sample solution 20 μ l, injection liquid chromatography, measures.
In characteristic spectrum, there is a sharp-pointed characteristic peak " peak S " at retention time 15.537min.Its molecular weight is 88070, and result shows that the agent of blood clam extract particles is to make with blood clam, proceeds assay.
Get granule porphyrize, precision takes 2.139g, containing blood clam extract 1.925g, adds 19.25ml water, and ultrasonic making is uniformly dispersed, and adds 13% trichloroacetic acid 33ml, mixes, and leaves standstill 40 minutes, filters, and gets filter paper and filter residue and drying, obtains test sample.Test sample is measured according to n2 method (annex IX L first method of " Chinese Pharmacopoeia " version in 2010), and the every g of blood clam extract is containing blood clam polypeptide 0.137g.
Embodiment 5
Get respectively the blood clam in the different places of production, prepare 3 batches of blood clam extract pills by the method for embodiment 2, extract respectively sample A, sample B and the sample C of three crowdes, differentiate and assay.3 batches of measurement results are:
In sample A characteristic spectrum, have a sharp-pointed characteristic peak " peak S " at retention time 15.347min, its molecular weight is 88070, and result shows that pill is to make with blood clam.Proceed assay.The every g of blood clam extract is containing blood clam polypeptide 1.986g.
In sample B characteristic spectrum, have a sharp-pointed characteristic peak " peak S " at retention time 15.854min, its molecular weight is 88070, and result shows that pill is to make with blood clam.Proceed assay.The every g of blood clam extract is containing blood clam polypeptide 1.681g.
In sample A characteristic spectrum, have a sharp-pointed characteristic peak " peak S " at retention time 15.622min, its molecular weight is 88070, and result shows that pill is to make with blood clam.Proceed assay.The every g of blood clam extract is containing blood clam polypeptide 0.678g.

Claims (5)

1. a content assaying method for blood clam protein and peptide, is characterized in that first determining that by gel chromatographic columns high performance liquid chromatography the polypeptide in sample is blood clam polypeptide, then measures content with nitriding.
2. determine that according to the gel chromatographic columns high performance liquid chromatography of claim 1 polypeptide in sample is blood clam polypeptide, it is characterized in that concrete steps are as follows:
(1) chromatographic condition and system flexibility: the gel chromatographic columns that is filling agent with hydrophilic spherical superpolymer; Taking the phosphate buffer of 0.05mol/L as mobile phase; Detecting wavelength is 280 nm; Column temperature: 25 DEG C; Flow velocity 0.4ml/min; Detect wavelength 280nm; Number of theoretical plate calculates and is not less than 5000 by protein molecular weight 100000;
(2) take sample 10g, add 12 times of ultrasonic extraction 30 min of water, centrifugal 10 min, get upper strata liquid, filter, filtrate is mark 60%(w/v by volume) add ammonium sulfate, 0~4 DEG C of placement is spent the night, centrifugal, gets precipitation, the 10ml that adds water dissolves, and the ammonium bicarbonate soln taking 1% is dislysate, the dialysis membrane that is 3500 with molecular cut off, under 0~4 DEG C of condition, fully dialysis, is transferred to solution in dialysis membrane in 50ml measuring bottle water constant volume, 0~4 DEG C of preservation, obtains blood clam polypeptide solution;
(3) get blood clam polypeptide solution 10 μ l, injection liquid chromatography, measures, and records collection of illustrative plates; If there is blood clam polypeptide in collection of illustrative plates within retention time 15.6min ± 5%.
3. measure content method according to the nitriding of claim 1, it is characterized in that taking sample 0.5-2g, add 20-40 times of water, ultrasonic making is uniformly dispersed, and adds 10-20% trichloroacetic acid 15-40ml, mix, leave standstill 20-50 minute, filter, get filter paper and filter residue and drying, according to annex IX L first method of " Chinese Pharmacopoeia " version in 2010, n2 method is measured the content of blood clam polypeptide.
4. according to the content assaying method of a kind of blood clam protein and peptide of claim 1 or claim 3, it is characterized in that in preparation, every g blood clam extract must not be less than 0.12g containing blood clam polypeptide, content is higher, better efficacy.
5. according to the content assaying method of a kind of blood clam protein and peptide of claim 1 or claim 2 or claim 3 or claim 4, it is characterized in that can be used for the assay of the various preparations of blood clam extract.
CN201410186505.1A 2014-05-06 2014-05-06 A kind of content assaying method of blood clam protein Active CN103954704B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410186505.1A CN103954704B (en) 2014-05-06 2014-05-06 A kind of content assaying method of blood clam protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410186505.1A CN103954704B (en) 2014-05-06 2014-05-06 A kind of content assaying method of blood clam protein

Publications (2)

Publication Number Publication Date
CN103954704A true CN103954704A (en) 2014-07-30
CN103954704B CN103954704B (en) 2016-01-20

Family

ID=51332004

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410186505.1A Active CN103954704B (en) 2014-05-06 2014-05-06 A kind of content assaying method of blood clam protein

Country Status (1)

Country Link
CN (1) CN103954704B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104825496A (en) * 2015-04-19 2015-08-12 青岛大学 Blood clam extract and application thereof in medicaments for promoting postpartum uterine contraction
CN110632229A (en) * 2019-09-24 2019-12-31 华兰生物工程重庆有限公司 Method for detecting protein content of human immunoglobulin (pH4) infused in static environment by high performance liquid chromatograph

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101037469A (en) * 2006-03-16 2007-09-19 中国海洋大学 Method for extracting small molecule active peptides from scapharca subcrenata
CN103254302A (en) * 2013-04-01 2013-08-21 于荣敏 Method for separation of antitumor polypeptide compound from Arca subcrenata Lischke and application
CN103254303A (en) * 2013-04-01 2013-08-21 于荣敏 Preparation method and application of antineoplastic active polypeptide component in Arca subcrenata Lischke

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101037469A (en) * 2006-03-16 2007-09-19 中国海洋大学 Method for extracting small molecule active peptides from scapharca subcrenata
CN103254302A (en) * 2013-04-01 2013-08-21 于荣敏 Method for separation of antitumor polypeptide compound from Arca subcrenata Lischke and application
CN103254303A (en) * 2013-04-01 2013-08-21 于荣敏 Preparation method and application of antineoplastic active polypeptide component in Arca subcrenata Lischke

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MASAE SEKINE 等: "Automated column-switching high-performance liquid chromatography system for quantifying N-methyl-DD- and -LL-aspartate", 《ANALYTICAL BIOCHEMISTRY》, vol. 310, no. 1, 1 November 2002 (2002-11-01), pages 114 - 121 *
何赟绵 等: "毛蚶多糖的分离纯化和免疫活性测定", 《中国海洋药物杂志》, vol. 26, no. 2, 30 April 2007 (2007-04-30), pages 23 - 26 *
刘思聪: "毛蚶天然多肽提取纯化及其体外抗氧化能力和抑制肿瘤活性的初步研究", 《中国优秀硕士学位论文全文数据库(工程科技Ⅰ辑)》, 15 March 2014 (2014-03-15), pages 024 - 272 *
徐彬 等: "毛蚶血红蛋白的分离纯化及其类酚氧化酶活性研究", 《中国科技论文在线》, 19 December 2012 (2012-12-19), pages 1 - 9 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104825496A (en) * 2015-04-19 2015-08-12 青岛大学 Blood clam extract and application thereof in medicaments for promoting postpartum uterine contraction
CN110632229A (en) * 2019-09-24 2019-12-31 华兰生物工程重庆有限公司 Method for detecting protein content of human immunoglobulin (pH4) infused in static environment by high performance liquid chromatograph

Also Published As

Publication number Publication date
CN103954704B (en) 2016-01-20

Similar Documents

Publication Publication Date Title
CN108912236A (en) A kind of Dendrobidium huoshanness refined polysaccharide and preparation method thereof with antitumor action
JP6389958B2 (en) Medicinal use of anti-tumor for rutile pentacyclic triterpene saponins
CN101502579B (en) Chinese medicinal composition for treating digestive tumor and preparation method thereof
CN102210737A (en) Sweet potato leaf extract and preparation method and use thereof
CN103954704B (en) A kind of content assaying method of blood clam protein
CN102507834B (en) Quality control method for eight-flavor agilawood preparations
CN101239110A (en) Prepared Chinese medicine capsule and its preparation and quality control method
CN103830301A (en) Flos chrysanthemi with liver tonifying function and application thereof
CN105744941A (en) Ephedra extract stripped of ephedrine alkaloids, method for producing same and use of same
CN103610699A (en) Extraction method of land slug and anti-lung cancer application of land slug
CN100427076C (en) Medicinal preparation for treating embolus and its preparation method
CN103969367B (en) A kind of discrimination method of blood clam protein
CN103969384B (en) A kind of content assaying method of blood clam polysaccharide
CN102319420B (en) The application of turtle peptide in pharmacy
TWI379685B (en)
CN101081250A (en) Potygonum multiflorum thunb extract medicament for treating anemia and the preparing method thereof
CN103830374A (en) Application of three-leaf glycolipid-removal medicine in hyperuricemia
CN101433564B (en) Use of water chestnut extract in preparing medicament for treating leukaemia
CN103969366B (en) A kind of content assaying method of blood clam
CN113134025A (en) Application of broccoli extract in preventing and treating leukopenia
CN108186693B (en) Preparation method of paecilomyces hepiali active substance for reducing uric acid or treating hyperuricemia, active substance prepared by method and application thereof
CN106880784A (en) It is a kind of with fatigue-relieving, the Chinese medicine composition of anti-aging and its application
CN102727867B (en) Antineoplastic pharmaceutical composition and application thereof, kit and package
CN105535050A (en) Radix angelica sinensis antitumor medicine
CN102920746B (en) Worm grass and Chinese blister beetle composition, enteric preparation, and application and preparation thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 250014 81 thousand Buddha Shandong Road, Lixia District, Ji'nan, Shandong

Patentee after: Shandong Zhonghong Kang Pharmaceutical Technology Development Co Ltd

Address before: 250014 No. 4, West building, Shandong Academy of Sciences, 19 Shandong Road, Lixia Road, Lixia District, Shandong

Patentee before: Jinan Kangzhong Medicin Science & Technology Co., Ltd.